Crinetics Pharmaceuticals Inc. (CRNX) at a glance

Crinetics Pharmaceuticals Inc. (CRNX) is a mid-cap Healthcare company. It trades at $84.98, with a 86% profit margin and revenue growth of 2873.4%. It does not pay a dividend. Vestovix scores it 73/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$84.98

Market cap

$3.63B

P/E ratio

n/a

Dividend yield

None

Beta

0.24

52-week range

$30.25 to $84.89